The association between physician trust and prostate-specific antigen screening: Implications for shared decision-making

Zachary Klaassen, Christopher J.D. Wallis, Hanan Goldberg, Thenappan Chandrasekar, Neil E. Fleshner, Antonio Finelli, Girish S. Kulkarni, Allan S. Detsky, Raj Satkunasivam

Research output: Contribution to journalArticle

Abstract

Introduction: Shared decision-making is widely recommended when men are considering prostate cancer screening with prostate-specific antigen (PSA). The role of patients’ trust in cancer information from their physician in such decisions is unknown. Methods: We identified male respondents ≥18 years of age from the Health Information National Trends Survey, a population-based survey of people living in the U.S. (2011–014). We assessed the association between degree of trust in cancer information from respondent’s physician with patient-reported receipt of PSA screening and patient-reported discussion of PSA screening with their physician. Results: Among 5069 eligible respondents, 3606 (71.1%) men reported trusting cancer information from their physician “a lot,” 1186 (23.4%) “somewhat,” 219 (4.3%) “a little,” and 58 (1.1%) “not at all.” A total of 2655 (52.4%) men reported receiving PSA screening. The degree of trust an individual had in his physician for cancer information was strongly associated with his likelihood of having received PSA screening (ptrend<0.0001) (54.9% “a lot” vs. 27.6% “not at all”). These findings persisted after multivariable regression. Similarly, men who had high levels of trust in their physician were more likely to have discussed PSA screening with a strong trend across strata (ptrend<0.0001). Conclusions: The level of trust an individual has in cancer information from his physician is strongly associated with his likelihood of discussing and undergoing PSA screening. As rationale, implementation of PSA screening requires shared decision-making, and the level of trust an individual has in his physician has important implications for dissemination of PSA screening guidelines.

Original languageEnglish (US)
Pages (from-to)395-400
Number of pages6
JournalCanadian Urological Association Journal
Volume12
Issue number12
DOIs
StatePublished - Dec 2018

Fingerprint

Prostate-Specific Antigen
Decision Making
Physicians
Neoplasms
Early Detection of Cancer
Prostatic Neoplasms
Surveys and Questionnaires
Guidelines
Health

ASJC Scopus subject areas

  • Urology

Cite this

The association between physician trust and prostate-specific antigen screening : Implications for shared decision-making. / Klaassen, Zachary; Wallis, Christopher J.D.; Goldberg, Hanan; Chandrasekar, Thenappan; Fleshner, Neil E.; Finelli, Antonio; Kulkarni, Girish S.; Detsky, Allan S.; Satkunasivam, Raj.

In: Canadian Urological Association Journal, Vol. 12, No. 12, 12.2018, p. 395-400.

Research output: Contribution to journalArticle

Klaassen, Z, Wallis, CJD, Goldberg, H, Chandrasekar, T, Fleshner, NE, Finelli, A, Kulkarni, GS, Detsky, AS & Satkunasivam, R 2018, 'The association between physician trust and prostate-specific antigen screening: Implications for shared decision-making', Canadian Urological Association Journal, vol. 12, no. 12, pp. 395-400. https://doi.org/10.5489/cuaj.5351
Klaassen, Zachary ; Wallis, Christopher J.D. ; Goldberg, Hanan ; Chandrasekar, Thenappan ; Fleshner, Neil E. ; Finelli, Antonio ; Kulkarni, Girish S. ; Detsky, Allan S. ; Satkunasivam, Raj. / The association between physician trust and prostate-specific antigen screening : Implications for shared decision-making. In: Canadian Urological Association Journal. 2018 ; Vol. 12, No. 12. pp. 395-400.
@article{5bbb2766b31d45cfbdea44eda07d57c9,
title = "The association between physician trust and prostate-specific antigen screening: Implications for shared decision-making",
abstract = "Introduction: Shared decision-making is widely recommended when men are considering prostate cancer screening with prostate-specific antigen (PSA). The role of patients’ trust in cancer information from their physician in such decisions is unknown. Methods: We identified male respondents ≥18 years of age from the Health Information National Trends Survey, a population-based survey of people living in the U.S. (2011–014). We assessed the association between degree of trust in cancer information from respondent’s physician with patient-reported receipt of PSA screening and patient-reported discussion of PSA screening with their physician. Results: Among 5069 eligible respondents, 3606 (71.1{\%}) men reported trusting cancer information from their physician “a lot,” 1186 (23.4{\%}) “somewhat,” 219 (4.3{\%}) “a little,” and 58 (1.1{\%}) “not at all.” A total of 2655 (52.4{\%}) men reported receiving PSA screening. The degree of trust an individual had in his physician for cancer information was strongly associated with his likelihood of having received PSA screening (ptrend<0.0001) (54.9{\%} “a lot” vs. 27.6{\%} “not at all”). These findings persisted after multivariable regression. Similarly, men who had high levels of trust in their physician were more likely to have discussed PSA screening with a strong trend across strata (ptrend<0.0001). Conclusions: The level of trust an individual has in cancer information from his physician is strongly associated with his likelihood of discussing and undergoing PSA screening. As rationale, implementation of PSA screening requires shared decision-making, and the level of trust an individual has in his physician has important implications for dissemination of PSA screening guidelines.",
author = "Zachary Klaassen and Wallis, {Christopher J.D.} and Hanan Goldberg and Thenappan Chandrasekar and Fleshner, {Neil E.} and Antonio Finelli and Kulkarni, {Girish S.} and Detsky, {Allan S.} and Raj Satkunasivam",
year = "2018",
month = "12",
doi = "10.5489/cuaj.5351",
language = "English (US)",
volume = "12",
pages = "395--400",
journal = "Canadian Urological Association Journal",
issn = "1920-1214",
publisher = "Canadian Urological Association",
number = "12",

}

TY - JOUR

T1 - The association between physician trust and prostate-specific antigen screening

T2 - Implications for shared decision-making

AU - Klaassen, Zachary

AU - Wallis, Christopher J.D.

AU - Goldberg, Hanan

AU - Chandrasekar, Thenappan

AU - Fleshner, Neil E.

AU - Finelli, Antonio

AU - Kulkarni, Girish S.

AU - Detsky, Allan S.

AU - Satkunasivam, Raj

PY - 2018/12

Y1 - 2018/12

N2 - Introduction: Shared decision-making is widely recommended when men are considering prostate cancer screening with prostate-specific antigen (PSA). The role of patients’ trust in cancer information from their physician in such decisions is unknown. Methods: We identified male respondents ≥18 years of age from the Health Information National Trends Survey, a population-based survey of people living in the U.S. (2011–014). We assessed the association between degree of trust in cancer information from respondent’s physician with patient-reported receipt of PSA screening and patient-reported discussion of PSA screening with their physician. Results: Among 5069 eligible respondents, 3606 (71.1%) men reported trusting cancer information from their physician “a lot,” 1186 (23.4%) “somewhat,” 219 (4.3%) “a little,” and 58 (1.1%) “not at all.” A total of 2655 (52.4%) men reported receiving PSA screening. The degree of trust an individual had in his physician for cancer information was strongly associated with his likelihood of having received PSA screening (ptrend<0.0001) (54.9% “a lot” vs. 27.6% “not at all”). These findings persisted after multivariable regression. Similarly, men who had high levels of trust in their physician were more likely to have discussed PSA screening with a strong trend across strata (ptrend<0.0001). Conclusions: The level of trust an individual has in cancer information from his physician is strongly associated with his likelihood of discussing and undergoing PSA screening. As rationale, implementation of PSA screening requires shared decision-making, and the level of trust an individual has in his physician has important implications for dissemination of PSA screening guidelines.

AB - Introduction: Shared decision-making is widely recommended when men are considering prostate cancer screening with prostate-specific antigen (PSA). The role of patients’ trust in cancer information from their physician in such decisions is unknown. Methods: We identified male respondents ≥18 years of age from the Health Information National Trends Survey, a population-based survey of people living in the U.S. (2011–014). We assessed the association between degree of trust in cancer information from respondent’s physician with patient-reported receipt of PSA screening and patient-reported discussion of PSA screening with their physician. Results: Among 5069 eligible respondents, 3606 (71.1%) men reported trusting cancer information from their physician “a lot,” 1186 (23.4%) “somewhat,” 219 (4.3%) “a little,” and 58 (1.1%) “not at all.” A total of 2655 (52.4%) men reported receiving PSA screening. The degree of trust an individual had in his physician for cancer information was strongly associated with his likelihood of having received PSA screening (ptrend<0.0001) (54.9% “a lot” vs. 27.6% “not at all”). These findings persisted after multivariable regression. Similarly, men who had high levels of trust in their physician were more likely to have discussed PSA screening with a strong trend across strata (ptrend<0.0001). Conclusions: The level of trust an individual has in cancer information from his physician is strongly associated with his likelihood of discussing and undergoing PSA screening. As rationale, implementation of PSA screening requires shared decision-making, and the level of trust an individual has in his physician has important implications for dissemination of PSA screening guidelines.

UR - http://www.scopus.com/inward/record.url?scp=85058065824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058065824&partnerID=8YFLogxK

U2 - 10.5489/cuaj.5351

DO - 10.5489/cuaj.5351

M3 - Article

AN - SCOPUS:85058065824

VL - 12

SP - 395

EP - 400

JO - Canadian Urological Association Journal

JF - Canadian Urological Association Journal

SN - 1920-1214

IS - 12

ER -